2014
DOI: 10.1007/s13721-014-0066-x
|View full text |Cite
|
Sign up to set email alerts
|

Binding affinity analysis and ADMET prediction of epigallocatechine gallate (EGCG) derivatives for AP-1 protein: a drug target for liver cancer

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
3
0

Year Published

2018
2018
2022
2022

Publication Types

Select...
4
3

Relationship

1
6

Authors

Journals

citations
Cited by 9 publications
(3 citation statements)
references
References 41 publications
0
3
0
Order By: Relevance
“…The activator protein-1 (AP-1) could regulate the transformation of tumor cells and the EGCG showed inhibitory effect on AP-1 protein . In addition, the EGCG acetylated derivatives have greater affinity with AP-1 protein on the target site of Ser 278, Asp 163, Asp 170, Arg 281, and Arg 288 by hydrogen bonds interactions . The inhibition of AP-1 protein could further up regulate the tumor suppressor gene p53 along with the reducing effect on tumor activity.…”
Section: Biological Activitiesmentioning
confidence: 99%
See 1 more Smart Citation
“…The activator protein-1 (AP-1) could regulate the transformation of tumor cells and the EGCG showed inhibitory effect on AP-1 protein . In addition, the EGCG acetylated derivatives have greater affinity with AP-1 protein on the target site of Ser 278, Asp 163, Asp 170, Arg 281, and Arg 288 by hydrogen bonds interactions . The inhibition of AP-1 protein could further up regulate the tumor suppressor gene p53 along with the reducing effect on tumor activity.…”
Section: Biological Activitiesmentioning
confidence: 99%
“…40 In addition, the EGCG acetylated derivatives have greater affinity with AP-1 protein on the target site of Ser 278, Asp 163, Asp 170, Arg 281, and Arg 288 by hydrogen bonds interactions. 41 The inhibition of AP-1 protein could further up regulate the tumor suppressor gene p53 along with the reducing effect on tumor activity. Due to the crosstalk between GTP-induced cell signaling pathways, GTE or GTP were both reported to effectively prevent the early stages of cancer, while the combined use of EGCG, EGCG derivatives and anticancer drugs exert synergistic inhibition on the proliferation of CSC, which altogether represent promising therapeutic approaches for human cancers.…”
Section: ■ Biological Activitiesmentioning
confidence: 99%
“…Ligand optimization is required to balance the physicochemical properties and pharmacokinetics of a ligand so that it can qualify for the criteria of the candidate drug. Docking tools evaluate the binding affinity and interaction of ligands with the target binding sites and help screen some top‐scoring ligands from a vast set of chemical structures (Sagar et al, 2014).…”
Section: Introductionmentioning
confidence: 99%